Lotus Ventures Inc. (CSE:J, FRA:LV9, OTC:LTTSF) (the “Company” or “Lotus”) has successfully harvested its initial batch of cannabis comprised of high-quality and award-winning strains. Naturally, the harvest, drying, and curing stages are vital to a producer’s final product, and our team feels confident with their experience in each stage.

Subsequent to drying and trimming the cannabis for two-to-three weeks, Lotus will then send a representative sample to a third-party laboratory for microbiological testing. Once the Company has received a Confirmation of Analysis (COA) confirming the product conforms to Health Canada’s testing requirements, bulk shipments are expected to be delivered to its streaming partner Auxly Cannabis Group Inc. immediately.

New Investor Presentation

With the recent news regarding the vaping industry, Lotus believes it has taken the right approach to focus on the cultivation aspect of the business before rushing into the next wave of value-added products. As we have seen in mature American markets, dried cannabis flower continues to command higher market share, and the Company does not see this trend changing in the near term as more Canadian flower consumers transition into licensed retail channels.

To read more about these trends and how we expect to reach our business objectives, download our new investor presentation below.

Link: https://gallery.mailchimp.com/443ef150b49b3f9ae9280d318/files/b59914c5-2a15-4c0d-b893-b95be85bc872/LotusInvestorDeck_compressed.pdf


Lotus Ventures Inc.

“Dale McClanaghan”
Dale McClanaghan, President and CEO

About Lotus Ventures Inc.

Lotus Ventures Inc. (CSE: J) is an Okanagan-based licensed producer focused on growing exceptional cannabis products for the wholesale and recreational market in Canada. Lotus operates an innovative 22,500 square foot growing facility with access to unique proven strains and an entirely handcrafted production process created by one of the regions most experienced growing teams.

For Further Information:

Dale McClanaghan, CEO: dalemcclanaghan@gmail.com 604-644-9844

Daniel McRobert, Investor Relations: investors@lotuscannabis.ca 604-842-4625

The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release.

Click here to connect with Lotus Ventures Inc (CSE:J) for an Investor Presentation.


American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.

Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.

Keep reading... Show less

An Emerging Markets Sponsored Commentary

Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.

Keep reading... Show less

As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.

A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.

Keep reading... Show less

The product will include polyphenols known to have significant health benefits.

BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.

The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).

Keep reading... Show less